Alison Fielding, a member of the Kidney Cancer Support Network (KCSN) and a patient expert for the NICE nivolumab (Opdivo) appraisal, was interviewed on Sky News last week about the fantastic news that NICE have approved nivolumab for previously treated kidney cancer – well done Alison! Alison has advanced kidney cancer.

See Alison’s interview here